Burzynski Research Institute, Inc. (BZYR)

Market Cap	1.12M -76.5%
Revenue (ttm)	n/a
Net Income	-1.29M
EPS	-0.01
Shares Out	131.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,252
Open	0.0103
Previous Close	0.0080
Day's Range	0.0090 - 0.0103
52-Week Range	0.0067 - 0.0550
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 10, 2026

About BZYR

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1977
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: BZYR

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 16, 2026

Data Sources Report a data error